Scripps 40th New Treatments in Chronic Liver Disease 2026
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
Description
Include: 14 videos Only no PDFs
Target Audience: hepatologists, gastroenterologists, internists, transplant specialists
Overview
New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.
Objectives
Upon completion of this activity, participants should be able to:
- Cite new strategies for identifying and managing metabolic liver disease.
- Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
- Discuss potential new treatments for alcohol-related liver disease.
- Summarize novel markers and therapies in PBC and PSC.
- Evaluate liver masses and new therapeutic options for HCC.
- Employ strategies for treating and managing ascites and hepatorenal syndrome.
